BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12624190)

  • 1. Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection.
    Pieper GM; Halligan NL; Hilton G; Konorev EA; Felix CC; Roza AM; Adams MB; Griffith OW
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3125-30. PubMed ID: 12624190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical change in antioxidant enzyme gene expression and activity in acute cardiac rejection: role of inducible nitric oxide synthase.
    Nilakantan V; Zhou X; Hilton G; Roza AM; Adams MB; Johnson CP; Pieper GM
    Mol Cell Biochem; 2005 Feb; 270(1-2):39-47. PubMed ID: 15792352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron spin resonance analysis of heme-nitrosyl and reduced iron-sulfur centered complexes in allogeneic, heterotopic cardiac transplants: effects of treatment with pyrrolidine dithiocarbamate.
    Nakanishi AL; Roza AM; Adams MB; Seibel R; Moore-Hilton G; Kalyanaraman B; Pieper GM
    Free Radic Biol Med; 1998 Jul; 25(2):201-7. PubMed ID: 9667497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejection.
    Pieper GM; Roza AM; Adams MB; Hilton G; Johnson M; Felix CC; Kampalath B; Darkes M; Wanggui Y; Cameron B; Fricker SP
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):441-8. PubMed ID: 11862124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational modification of manganese superoxide dismutase in acutely rejecting cardiac transplants: role of inducible nitric oxide synthase.
    Nilakantan V; Halligan NL; Nguyen TK; Hilton G; Khanna AK; Roza AM; Johnson CP; Adams MB; Griffith OW; Pieper GM
    J Heart Lung Transplant; 2005 Oct; 24(10):1591-9. PubMed ID: 16210135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.
    Pieper GM; Ionova IA; Cooley BC; Migrino RQ; Khanna AK; Whitsett J; Vásquez-Vivar J
    J Pharmacol Exp Ther; 2009 Jun; 329(3):890-9. PubMed ID: 19307452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
    Moien-Afshari F; Choy JC; McManus BM; Laher I
    J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection.
    Pieper GM; Nilakantan V; Hilton G; Zhou X; Khanna AK; Halligan NL; Felix CC; Kampalath B; Griffith OW; Hayward MA; Roza AM; Adams MB
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H525-34. PubMed ID: 14715498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection.
    Pieper GM; Nilakantan V; Hilton G; Halligan NL; Felix CC; Kampalath B; Khanna AK; Roza AM; Johnson CP; Adams MB
    Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1542-51. PubMed ID: 12679325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection.
    Vos IH; Joles JA; Schurink M; Weckbecker G; Stojanovic T; Rabelink TJ; Gröne HJ
    Eur J Pharmacol; 2000 Mar; 391(1-2):31-8. PubMed ID: 10720632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial nuclear factor-kappaB activity and nitric oxide production in rejecting cardiac allografts.
    Cooper M; Lindholm P; Pieper G; Seibel R; Moore G; Nakanishi A; Dembny K; Komorowski R; Johnson C; Adams M; Roza A
    Transplantation; 1998 Oct; 66(7):838-44. PubMed ID: 9798691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts.
    Pieper GM; Nilakantan V; Zhou X; Khanna AK; Johnson CP; Roza AM; Adams MB; Hilton G; Felix CC
    J Pharmacol Exp Ther; 2005 Feb; 312(2):774-9. PubMed ID: 15347735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide and superoxide in acute cardiac allograft rejection in rats.
    Akizuki E; Akaike T; Okamoto S; Fujii S; Yamaguchi Y; Ogawa M; Maeda H
    Proc Soc Exp Biol Med; 2000 Nov; 225(2):151-9. PubMed ID: 11044258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguanidine.
    Ziolo MT; Dollinger SJ; Wahler GM
    J Mol Cell Cardiol; 1998 May; 30(5):1009-17. PubMed ID: 9618241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant treatment inhibits activation of myocardial nuclear factor kappa B and inhibits nitrosylation of myocardial heme protein in cardiac transplant rejection.
    Pieper GM; Olds C; Hilton G; Lindholm PF; Adams MB; Roza AM
    Antioxid Redox Signal; 2001 Feb; 3(1):81-8. PubMed ID: 11291601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ measurement of nitric oxide production in cardiac isografts and rejecting allografts by an electrochemical method.
    Joshi MS; Lancaster JR; Liu X; Ferguson TB
    Nitric Oxide; 2001 Dec; 5(6):561-5. PubMed ID: 11730363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection.
    Worrall NK; Misko TP; Botney MD; Sullivan PM; Hui JJ; Suau GM; Manning PT; Ferguson TB
    Ann Thorac Surg; 1999 Mar; 67(3):716-22. PubMed ID: 10215216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection.
    Cai B; Roy DK; Sciacca R; Michler RE; Cannon PJ
    Int J Cardiol; 1995 Jul; 50(3):243-51. PubMed ID: 8537148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of myocardial nitrosyl complex formation by a nitric oxide scavenger prolongs cardiac allograft survival.
    Pieper GM; Cooper M; Johnson CP; Adams MB; Felix CC; Roza AM
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):114-20. PubMed ID: 10630741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.